CoLucid Pharmaceuticals Overview
- Year Founded
-
2005
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
M&A
- Financing Rounds
-
11
CoLucid Pharmaceuticals General Information
Description
Developer of therapeutics for neurological diseases. The company develops new treatments for migraine headaches, pain, and other neurological disorders.
Contact Information
Website
www.colucid.comCorporate Office
- P.O. Box 425227
- Cambridge, MA 02142
- United States
Corporate Office
- P.O. Box 425227
- Cambridge, MA 02142
- United States
CoLucid Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CoLucid Pharmaceuticals Comparisons
Industry
Financing
Details
CoLucid Pharmaceuticals Competitors (4)
One of CoLucid Pharmaceuticals’s 4 competitors is ACADIA Pharmaceuticals, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals | Formerly VC-backed | San Diego, CA | ||||
| Sio Gene Therapies | Formerly VC-backed | New York, NY | ||||
| Panbela Therapeutics | Formerly VC-backed | Waconia, MN | ||||
| Minerva Neurosciences | Formerly VC-backed | Burlington, MA |
CoLucid Pharmaceuticals Patents
CoLucid Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2024178323-A | Composition and method related to pyridinoyl-piperidine 5-ht1f agonist | Active | 06-Dec-2016 | ||
| JP-2022000451-A | Compositions and methods related to pyridinoylpiperdine 5-ht1f agonists | Pending | 06-Dec-2016 | ||
| US-20200087279-A1 | Compositions and methods related to pyridinoylpiperdine 5-ht1f agonists | Active | 06-Dec-2016 | ||
| AU-2017373784-A1 | Compositions and methods related to pyridinoylpiperidine 5-ht1f agonists | Active | 06-Dec-2016 | ||
| AU-2017373784-B2 | Compositions and methods related to pyridinoylpiperidine 5-ht1f agonists | Active | 06-Dec-2016 | C07D401/06 |
CoLucid Pharmaceuticals Signals
CoLucid Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CoLucid Pharmaceuticals FAQs
-
When was CoLucid Pharmaceuticals founded?
CoLucid Pharmaceuticals was founded in 2005.
-
Where is CoLucid Pharmaceuticals headquartered?
CoLucid Pharmaceuticals is headquartered in Cambridge, MA.
-
What is the size of CoLucid Pharmaceuticals?
CoLucid Pharmaceuticals has 7 total employees.
-
What industry is CoLucid Pharmaceuticals in?
CoLucid Pharmaceuticals’s primary industry is Drug Discovery.
-
Is CoLucid Pharmaceuticals a private or public company?
CoLucid Pharmaceuticals is a Private company.
-
What is the current valuation of CoLucid Pharmaceuticals?
The current valuation of CoLucid Pharmaceuticals is .
-
What is CoLucid Pharmaceuticals’s current revenue?
The current revenue for CoLucid Pharmaceuticals is .
-
How much funding has CoLucid Pharmaceuticals raised over time?
CoLucid Pharmaceuticals has raised $159M.
-
Who are CoLucid Pharmaceuticals’s investors?
Auriga Partners (Paris), Care Capital, Domain Associates, MPM BioImpact, and Novo Holdings are 5 of 11 investors who have invested in CoLucid Pharmaceuticals.
-
Who are CoLucid Pharmaceuticals’s competitors?
ACADIA Pharmaceuticals, Sio Gene Therapies, Panbela Therapeutics, and Minerva Neurosciences are competitors of CoLucid Pharmaceuticals.
-
When was CoLucid Pharmaceuticals acquired?
CoLucid Pharmaceuticals was acquired on 01-Mar-2017.
-
Who acquired CoLucid Pharmaceuticals?
CoLucid Pharmaceuticals was acquired by Lilly USA.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process